<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Han C</submitter><funding>Disciplinary Boost Program of Xijing Hospital</funding><pagination>1905184</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7889389</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2021</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>The purpose of this study was to evaluate the feasibility and safety of myocardial biopsy using a new approach, the Liwen procedure.&lt;h4>Background&lt;/h4>Myocardial biopsy is essential when other methods could not differentiate other etiologies from hypertrophic obstructive cardiomyopathy (HOCM). Our previous work using intramyocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy (Liwen procedure) may provide another approach to obtain the myocardial samples.&lt;h4>Method&lt;/h4>Seventeen patients with HOCM were enrolled for biopsies through percutaneously accessed intramyocardial septum and evaluated possible complications.&lt;h4>Results&lt;/h4>We obtained 31 specimens from 17 patients with a success rate of sample acquisition 100.0%. The number of myocardial sam</pubmed_abstract><journal>Journal of interventional cardiology</journal><pubmed_title>Trans-Septal Myocardial Biopsy in Hypertrophic Cardiomyopathy Using the Liwen Procedure: An Introduction of a Novel Technique.</pubmed_title><pmcid>PMC7889389</pmcid><funding_grant_id>XJZT18Z03</funding_grant_id><funding_grant_id>2018YBXM-SF-12-1</funding_grant_id><funding_grant_id>81981755</funding_grant_id><funding_grant_id>XJZT18MJ51</funding_grant_id><pubmed_authors>Zhou M</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Ta S</pubmed_authors><pubmed_authors>Hsi DH</pubmed_authors><pubmed_authors>Zuo L</pubmed_authors><pubmed_authors>Han C</pubmed_authors><pubmed_authors>Hu R</pubmed_authors><pubmed_authors>Wei L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Trans-Septal Myocardial Biopsy in Hypertrophic Cardiomyopathy Using the Liwen Procedure: An Introduction of a Novel Technique.</name><description>&lt;h4>Objective&lt;/h4>The purpose of this study was to evaluate the feasibility and safety of myocardial biopsy using a new approach, the Liwen procedure.&lt;h4>Background&lt;/h4>Myocardial biopsy is essential when other methods could not differentiate other etiologies from hypertrophic obstructive cardiomyopathy (HOCM). Our previous work using intramyocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy (Liwen procedure) may provide another approach to obtain the myocardial samples.&lt;h4>Method&lt;/h4>Seventeen patients with HOCM were enrolled for biopsies through percutaneously accessed intramyocardial septum and evaluated possible complications.&lt;h4>Results&lt;/h4>We obtained 31 specimens from 17 patients with a success rate of sample acquisition 100.0%. The number of myocardial sam</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-04T10:27:32.844Z</modification><creation>2021-02-27T08:16:55Z</creation></dates><accession>S-EPMC7889389</accession><cross_references><pubmed>33628143</pubmed><doi>10.1155/2021/1905184</doi></cross_references></HashMap>